Orion Corporation Financial Reporting in 2001

November 20, 2000 02:00 ET | Source: Orion Oyj Orion Oyj

Financial Statements for 2000 Wednesday, 21 February 2001,
8.30 a.m.

Interim Report 1-3/2001 Tuesday, 8 May 2001, 8.30 a.m.

Interim Report 1-6/2001 Wednesday, 8 August 2001, 8.30 a.m.

Interim Report 1-9/2001 Tuesday, 6 November 2001, 8.30 a.m.

Annual Report 2000 Friday, 16 March 2001

Annual General Meeting Thursday, 29 March, 2001
(preliminary date)

ORION CORPORATION

Jukka Viinanen

Henry Haarla

Recommended Reading

August 10, 2026 07:05 ET | Source: Orion Oyj

Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint

ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 10 AUGUST 2026 at 14.05 EEST Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary...
Read More

$Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint$
July 17, 2026 05:00 ET | Source: Orion Oyj

Orion Group Half-Year Financial Report January–June 2026

ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2026 17 JULY 2026 at 12:00 EEST Orion Group Half-Year Financial Report January–June 2026 April–June 2026 Highlights Net sales totalled EUR 521.6...
Read More